Vaxart Inc’s recently made public that its Director Watson W. Mark acquired Company’s shares for reported $13578.0 on Jun 18 ’24. In the deal valued at $0.68 per share,20,000 shares were bought. As a result of this transaction, Watson W. Mark now holds 78,125 shares worth roughly $32031.249999999996.
Oppenheimer initiated its Vaxart Inc [VXRT] rating to an Outperform in a research note published on August 15, 2024; the price target was $4. Cantor Fitzgerald began covering VXRT with “an Overweight” recommendation on November 02, 2021. B. Riley Securities revised its rating on June 29, 2021. It rated VXRT as “a Neutral” which previously was an “a Buy”.
Price Performance Review of VXRT
On Monday, Vaxart Inc [NASDAQ:VXRT] saw its stock fall -3.48% to $0.41. Over the last five days, the stock has lost -2.43%. Vaxart Inc shares have fallen nearly -38.83% since the year began. Nevertheless, the stocks have fallen -44.52% over the past one year. While a 52-week high of $1.07 was reached on 01/07/25, a 52-week low of $0.28 was recorded on 04/09/25. SMA at 50 days reached $0.4254, while 200 days put it at $0.6563.
Levels Of Support And Resistance For VXRT Stock
The 24-hour chart illustrates a support level at 0.3832, which if violated will result in even more drops to 0.3615. On the upside, there is a resistance level at 0.4258. A further resistance level may holdings at 0.4467. The Relative Strength Index (RSI) on the 14-day chart is 49.71, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0027, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 53.46%. Stochastics %K at 55.02% indicates the stock is a holding.
The most recent change occurred on June 24, 2021 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $13 price target.
